PortfoliosLab logoPortfoliosLab logo
UHS vs. GERN
Performance
Return for Risk
Drawdowns
Volatility
Dividends
Financials

Performance

UHS vs. GERN - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Universal Health Services, Inc. (UHS) and Geron Corporation (GERN). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, UHS achieves a -22.56% return, which is significantly lower than GERN's -2.27% return. Over the past 10 years, UHS has outperformed GERN with an annualized return of 3.45%, while GERN has yielded a comparatively lower -7.19% annualized return.


UHS

1D
3.15%
1M
6.39%
6M
-16.11%
YTD
-22.56%
1Y
3.79%
3Y*
7.03%
5Y*
1.51%
10Y*
3.45%
ALL TIME*
15.23%

GERN

1D
-3.73%
1M
-5.15%
6M
-5.84%
YTD
-2.27%
1Y
10.26%
3Y*
-26.20%
5Y*
1.12%
10Y*
-7.19%
ALL TIME*
-5.90%
*Multi-year figures are annualized to reflect compound growth (CAGR)

Liquidity Comparison


PositionAvg. Volume Value (2W)Avg. Volume Value (1M)Avg. Volume Value (3M)
$11.36M$12.76M$17.04M
$196.29M$163.61M$167.22M

UHS vs. GERN - Yearly Performance Comparison


2026 (YTD)202520242023202220212020201920182017
UHS
Universal Health Services, Inc.
-22.56%22.02%18.19%8.83%9.37%-5.16%-4.00%23.62%3.16%6.93%
GERN
Geron Corporation
-2.27%-62.71%67.77%-12.81%98.36%-23.27%16.91%36.00%-44.44%-13.04%

Correlation

The correlation between UHS and GERN is 0.02, meaning there was essentially no consistent relationship between their historical price movements. Each responded to its own set of market drivers.


Correlation
Correlation (1Y)
Focuses on recent behavior, but can change the most.

0.02

Correlation (3Y)
Balances recent behavior with more history.

0.08

Correlation (5Y)
Shows whether the relationship held over a longer period.

0.13

Correlation (10Y)
Provides a long-term view across more market conditions.

0.12

Correlation (All Time)
Calculated using the full available price history since Jul 31, 1996

0.18

The correlation between UHS and GERN shifts across timeframes, from 0.02 (1 year) to 0.18 (all time), reflecting how their relationship changes across market environments.

Fundamentals

Market Cap

UHS:

$10.20B

GERN:

$827.56M

EPS

UHS:

$31.93

GERN:

-$0.10

PS Ratio

UHS:

0.44

GERN:

4.39

Total Revenue (TTM)

UHS:

$18.11B

GERN:

$196.12M

Gross Profit (TTM)

UHS:

$8.80B

GERN:

$119.67M

EBITDA (TTM)

UHS:

$2.82B

GERN:

-$40.62M

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

UHS vs. GERN — Risk / Return Rank

Compare historical risk-adjusted metric ranks over the past 12 months.

UHS
UHS Risk / Return Rank: 4444
Overall Rank
UHS Sharpe Ratio Rank: 4646
Sharpe Ratio Rank
UHS Sortino Ratio Rank: 4040
Sortino Ratio Rank
UHS Omega Ratio Rank: 4141
Omega Ratio Rank
UHS Calmar Ratio Rank: 4646
Calmar Ratio Rank
UHS Martin Ratio Rank: 4545
Martin Ratio Rank

GERN
GERN Risk / Return Rank: 5252
Overall Rank
GERN Sharpe Ratio Rank: 5353
Sharpe Ratio Rank
GERN Sortino Ratio Rank: 5353
Sortino Ratio Rank
GERN Omega Ratio Rank: 5050
Omega Ratio Rank
GERN Calmar Ratio Rank: 5353
Calmar Ratio Rank
GERN Martin Ratio Rank: 5353
Martin Ratio Rank
The rank (0–100) uses a weighted average of the Sharpe, Sortino, Omega, Calmar, and Martin percentile ranks for the trailing 12 months. Higher means stronger historical risk-adjusted performance within the peer group.

UHS vs. GERN - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Universal Health Services, Inc. (UHS) and Geron Corporation (GERN). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.


UHSGERNDifference
Sharpe ratioReturn per unit of total volatility

-0.15

Sortino ratioReturn per unit of downside risk

-0.47

Omega ratioGain probability vs. loss probability

1.04

1.09

-0.05

Calmar ratioReturn relative to maximum drawdown

0.04

0.28

-0.24

Martin ratioReturn relative to average drawdown

0.08

0.61

-0.53

UHS vs. GERN - Sharpe Ratio Comparison

The current UHS Sharpe Ratio is 0.05, which is lower than the GERN Sharpe Ratio of 0.20. The chart below compares the historical Sharpe Ratios of UHS and GERN, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Drawdowns

UHS vs. GERN - Drawdown Comparison

The maximum UHS drawdown since its inception was -60.27%, smaller than the maximum GERN drawdown of -98.73%. Use the drawdown chart below to compare losses from any high point for UHS and GERN.


Loading charts...

Drawdown Indicators


UHSGERNDifference

Max Drawdown

Largest peak-to-trough decline

-60.27%

-98.73%

+38.46%

Max Drawdown (1Y)

Largest decline over 1 year

-42.00%

-43.59%

+1.59%

Max Drawdown (3Y)

Largest decline over 3 years

-42.00%

-78.98%

+36.98%

Max Drawdown (5Y)

Largest decline over 5 years

-43.73%

-78.98%

+35.25%

Max Drawdown (10Y)

Largest decline over 10 years

-56.30%

-86.09%

+29.79%

Current Drawdown

Current decline from peak

-30.80%

-98.15%

+67.35%

Average Drawdown

Average peak-to-trough decline

-14.90%

-86.21%

+71.31%

Ulcer Index

Depth and duration of drawdowns from previous peaks

21.71%

20.06%

+1.65%

Volatility

UHS vs. GERN - Volatility Comparison

The current volatility for Universal Health Services, Inc. (UHS) is 12.36%, while Geron Corporation (GERN) has a volatility of 16.52%. This indicates that UHS experiences smaller price fluctuations and is considered to be less risky than GERN based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


UHSGERNDifference

Volatility (1M)

Calculated over the trailing 1-month period

12.36%

16.52%

-4.16%

Volatility (6M)

Calculated over the trailing 6-month period

27.12%

46.49%

-19.37%

Volatility (1Y)

Calculated over the trailing 1-year period

32.05%

61.70%

-29.65%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

32.04%

81.29%

-49.25%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

34.50%

78.11%

-43.61%

Dividends

UHS vs. GERN - Dividend Comparison

UHS's dividend yield for the trailing twelve months is around 0.47%, while GERN has not paid dividends to shareholders.


PositionTTM20252024202320222021202020192018201720162015
GERN
Geron Corporation
0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%
UHS
Universal Health Services, Inc.
0.47%0.37%0.45%0.52%0.57%0.62%0.15%0.42%0.34%0.35%0.38%0.33%

Financials

UHS vs. GERN - Financials Comparison

This section allows you to compare key financial metrics between Universal Health Services, Inc. and Geron Corporation. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


Values in USD except per share items

UHS vs. GERN - Profitability Comparison

The chart below illustrates the profitability comparison between Universal Health Services, Inc. and Geron Corporation over time, highlighting three key metrics: Gross Profit Margin, Operating Margin, and Net Profit Margin.

Gross Margin
Operating Margin
Net Margin
Quarterly
Annual

UHS - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Aug 2026, Universal Health Services, Inc. reported a gross profit of 0.00 and revenue of 4.64B. Therefore, the gross margin over that period was 0.0%.

GERN - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Aug 2026, Geron Corporation reported a gross profit of 0.00 and revenue of 51.84M. Therefore, the gross margin over that period was 0.0%.

UHS - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Aug 2026, Universal Health Services, Inc. reported an operating income of 516.68M and revenue of 4.64B, resulting in an operating margin of 11.1%.

GERN - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Aug 2026, Geron Corporation reported an operating income of 158.00K and revenue of 51.84M, resulting in an operating margin of 0.3%.

UHS - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Aug 2026, Universal Health Services, Inc. reported a net income of 358.45M and revenue of 4.64B, resulting in a net margin of 7.7%.

GERN - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Aug 2026, Geron Corporation reported a net income of -3.64M and revenue of 51.84M, resulting in a net margin of -7.0%.


Frequently Asked Questions


UHS and GERN have a correlation of 0.02, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

GERN has higher volatility (16.52%) compared to UHS (12.36%). In terms of maximum drawdown, UHS dropped -60.27% vs GERN's -98.73%.

GERN currently has the higher Sharpe Ratio (0.20 vs 0.05), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for UHS and GERN

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer